# Avacta Group to hold Analyst Briefing

- Link: https://www.directorstalkinterviews.com/avacta-group-to-hold-analyst-briefing/412805492
- Published: 2020-02-13T08:28:57+00:00
- Author: Amilia Stone

**[Avacta](https://www.directorstalkinterviews.com/company/avacta-group-plc/avct.l)
Group plc** ([LON:AVCT](https://www.directorstalkinterviews.com/ftse-company/avacta-group-plc/avct.l)),
the developer of Affimer® biotherapeutics and reagents, will announce its financial
results for the 17 months ended 31 December 2019 on Tuesday, 21 April 2020.

An analyst briefing given by Alastair Smith, Chief Executive Officer and Tony Gardiner,
Chief Financial Officer, will be held at 09.30 hrs on Tuesday, 21 April 2020 at 
finnCap’s offices, 60 New Broad St, London EC2M 1JJ.

Avacta Group is developing novel cancer immunotherapies combining its two proprietary
platforms – Affimer^(®) biotherapeutics and pre|CISION™ tumour targeted chemotherapy.
With this approach, the Company aims to address the lack of a durable response to
current immunotherapies experienced by most patients. The Company’s therapeutics
development activities are based in Cambridge, UK.

Share on: